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Abstract
Background: The burden of disease of hearing disorders among adults is high, but a significant
part goes undetected. Screening programs in combination with the delivery of hearing aids can
alleviate this situation, but the economic attractiveness of such programs is unknown. This study
aims to evaluate the population-level costs, effects and cost-effectiveness of alternative delivering
hearing aids models in Tamil Nadu, India
Methods: In an observational study design, we estimated total costs and effects of two active
screening programs in the community in combination with the provision of hearing aids at
secondary care level, and the costs and effects of the provision of hearing aids at tertiary care level.
Screening and hearing aid delivery costs were estimated on the basis of program records and an
empirical assessment of health personnel time input. Household costs for seeking and undergoing
hearing health care were collected with a questionnaire (see Additional file 2). Health effects were
estimated on the basis of compliance with the hearing aid, and associated changes in disability, and
were expressed in disability-adjusted life years (DALYs) averted.
Results: Active screening and provision of hearing aids at the secondary care level costs around
Rs.7,000 (US$152) per patient, whereas provision of hearing aids at the tertiary care level costs Rs
5,693 (US$122) per patient. The cost per DALY averted was around RS 42,200 (US$900) at
secondary care level and Rs 33,900 (US$720) at tertiary care level. The majority of people did
consult other providers before being screened in the community. Costs of food and transport
ranged between Rs. 2 (US$0,04) and Rs. 39 (US$0,83).
Conclusion: Active screening and provision of hearing aids at the secondary care level is slightly
more costly than passive screening and fitting of hearing aids at the tertiary care level, but seems
also able to reach a higher coverage of hearing aids services. Although crude estimates indicate that
both passive and active screening programs can be cautiously considered as cost-effective
according to international thresholds, important questions remain regarding the implementation of
the latter.
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Background
The burden of hearing loss among adults is large. Accord-
ing to WHO estimates, some 413 million people suffer
from mild or greater hearing loss globally, an estimated
187 million people from moderate or greater hearing loss,
and 46 million people from severe or profound hearing
loss [1]. The provision of hearing aids has been proposed
as an effective approach, but a significant proportion of all
people with hearing disorders goes undetected, and as a
result relatively few people are fitted with hearing aids [2].
WHO estimates that only one-tenth of the global popula-
tion in need of hearing aids actually receives them [2].
In this respect, two important observations can be made.
Firstly, active screening for hearing disorders has been sug-
gested as an effective strategy to increase case detection,
and a number of studies in a range of developing coun-
tries have shown its feasibility in combination with provi-
sion of hearing aids [2]. However, no study has
systematically evaluated the costs of such programs, let
alone their cost-effectiveness in a developing country con-
text (such studies are available on the United Kingdom
[3,4], but results are obvious difficult to generalize). Sec-
ond, delivery of hearing aids often takes place at tertiary
health facility levels, and is managed by specialized audi-
ologists. There is little structured knowledge as to whether
hearing aids can also be effectively delivered at lower, e.g.,
secondary care level, and on the costs (or savings) associ-
ated with these alternative strategies. There is an urgent
need for research to answer these questions [2].
In response to these two observations, this paper reports
on the costs and health effects of two active screening pro-
grams in the community in combination with the provi-
sion of hearing aids at secondary care level, and the costs
and effects of the provision of hearing aids at tertiary care
level in three sites in Tamil Nadu, India, in the period
2007–2008. This study is part of a number of WWHearing
pilot projects on the delivery of hearing aids in developing
countries [5].
Methods
The study evaluated three different programs:
1. Active screening and fitting at secondary care level
Active screening in 62 communities in Karigiri through
hearing camps and fitting of hearing aids to 101 patients
by the community hearing workers in the Karigiri second-
ary level health facility. This program also fitted hearing
aids to 111 patients who presented themselves directly at
Karigiri secondary level health facility for treatment;
2. Active screening and fitting at secondary care level
Active screening in 63 communities in Vellore through
hearing camps and fitting of hearing aids to 163 patients
by the community hearing workers in Community Health
and Development (CHAD), a department of the Christian
Medical College, Vellore providing primary and second-
ary health care. This program also fitted hearing aids to 32
patients who presented themselves directly at CHAD for
treatment;
3. Passive screening and fitting at tertiary care level
Passive screening and fitting of hearing aids to 100
patients in the ENT department of the Christian Medical
College (CMC), a tertiary level health facility in Vellore.
In both active screening models (programs 1 and 2), com-
munity hearing workers screened adults in the commu-
nity. A selection of those receive a hearing assessment, for
eligible patients an ear mould impression was taken, and
the impressions were then sent for conversion into ear
moulds at tertiary care level (CMC). Subsequently, at the
secondary level health facility, the programmable hearing
aid was fitted by the community hearing worker. In both
programs 1 and 2, all people received monaural hearing
aids. People were referred in cases where disorders were
not treatable with hearing aids. The patient was followed-
up in a total of four visits within a year (at 2 weeks, 1
month, 3 months and 6 months) and after that at yearly
intervals, also by the community hearing worker. The pro-
grams also served patients who present themselves
directly for treatment. Community hearing workers
attended a three week training program on basic hearing
health care, including basic audiometry, ear mould
impression taking and hearing aid fitting.
In the passive screening mode (program 3), patients pre-
sented themselves at the outpatient department of the ter-
tiary level health facility, and were referred to the
audiology department in case of hearing problems. The
consultation with the audiologist included a physical and
a standard audiometric examination. People were referred
in cases where disorders were not treatable with hearing
aids. For patients eligible for a hearing aid, an ear mould
impression was taken by an ear mould technician. At a
second visit, a digital, programmable hearing aid was fit-
ted. In program 3, some people received monaural and
some binaural hearing aids. The patient was followed-up
in a total of four visits within a year (at 2 weeks, 1 month,
3 months and 6 months) and after that at yearly intervals.
In all programs, eligibility of patients for hearing aids was
determined with reference to WHO Guidelines for Hear-
ing Aids and Services for Developing Countries [2]. In all
programs, based on the diagnostic audiological assess-
ment, hearing aids were programmed to NAL-NL1 pre-
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scription standards [4] and fitted by the audiologists and
hearing care workers involved in the project. Evaluation of
each individual fitting was later performed and this
included aided hearing threshold measures, and speech
detection testing. Results from these measures will be con-
sidered in a future research report. The hearing health care
service was provided free of health care costs to the
patients.
The study had an observational design, in which all peo-
ple were followed during the course of their inclusion in
the program. The costing analysis followed WHO guide-
lines on costing and cost-effectiveness analysis [7] where
possible, and was based on the ingredient approach, i.e.,
separate reporting of prices and quantities. All costs were
estimated with base year 2007. Health care costs included
those of screening and hearing aid delivery, and were esti-
mated on the basis of a detailed assessment of program
records and an empirical assessment of health personnel
time input. The latter was obtained through a simple reg-
istration of the time that the health personnel (audiolo-
gists, hearing worker, or ear mould technician, depending
on the study site) spent on care for each person. These
data were collected for all programs. Household costs for
seeking and undergoing care were collected with a ques-
tionnaire, administered by the health personnel to the
patients. This included questions not only on costs of
travel and lodging, but also on foregone income, i.e., time
lost because of the program. In addition, household treat-
ment seeking patterns prior to the present programs were
assessed, including questions on associated costs. These
data were collected for all programs.
Guidelines on cost-effectiveness analysis (CEA) typically
advocate adoption of the societal perspective in the calcu-
lation of costs and effects [7,8]. This refers to the inclusion
of all changes in resource use, no matter who is paying the
costs, and includes health care costs (i.e., those that accrue
to the health care sector) and household costs (i.e., those
that accrue to patients and families). However, in practice,
cost-effectiveness analysis often only includes health care
costs, and one of the reasons for this is the difficulty of val-
uing and, therefore, estimating time costs [8]. As a com-
promise, we separately report the household costs of
seeking and undergoing care in the context of the present
program. In addition, we separately report household
costs of seeking and undergoing care prior to enrolment in
the present program.
We only include health effects and not effects of improved
hearing on labor productivity. To our knowledge, no
study has assessed the health state valuation of deafness
for adults in India, and following WHO guidelines on
CEA, we use health state valuations from the Global Bur-
den of Disease study [9]. The health state valuation for
deafness in adults (15 years and older) equals 0.216
(untreated) and 0.168 (treated). Subsequently, disability
adjusted life years (DALYs) averted were calculated for the
people included in the study. Since follow-up of the fitted
person was only limited in the study, we assumed a use of
the hearing aids for five years. In other words, every per-
son fitted with hearing aids gains 0.168 DALYs [calculated
as: 5*(0.216–0.168)], and discounted by 3% following
WHO guidelines on CEA [7]. We did not include any
health effects of the programs after this five year period.
The study was performed in the context of the routine
service program, and no specific ethical approval was
required. All respondents gave informed consent to their
participation in this study.
Results
Patient volumes and costs for the various programs are
summarized in Table 1 (details are available in Additional
file 1). The total number of people screened at camps
equaled 1,926 in program 1 and 1,648 in program 2. A
proportion of these were referred to the respective health
facilities, and 101 of these were fitted with hearing aids at
the secondary care level in program 1 and 163 in program
2. In addition to these people identified through active
screening, other people presented themselves directly for
treatment at the health facilities. Of those, 111 were fitted
with hearing aids at the secondary care level in program 1,
and 32 in program 2. At the tertiary care level, 100 people
were fitted with hearing aids (50 monaural and 50 binau-
ral).
Health care costs of the active screening programs
included fixed and variable costs (Additional file 1). Fixed
costs are defined here as costs that do not vary with the
number of people screened, and include costs of person-
nel involved in the program (such as that of management,
and of community hearing workers), equipment (such as
portable audiometers and otoscopes purchased by the
program), and materials. These costs are almost equal in
the two sites where the screening programs took place.
Variable costs are defined here as costs that do vary with
the number of people screened (and thus with the
number of camps) and/or treated. In program 1, 62 camps
were organized at a total costs of Rs. 97,224 (US$2,077),
whereas in program 2, 63 camps were organized at a total
cost of Rs. 64,340 (US$1,375). Other variable costs
include that of mould impression materials, hearing aids,
and outpatient visits for consultation and follow-up of
patients in the health facilities (either referred through
camps, or presented directly at the health facilities).
Total costs of the programs ranged from Rs 569,332
(US$12,165) in program 3 to Rs 1,383,120 (US$15,280)
in program 2. The total costs per person fitted with hear-
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ing aids ranged from Rs 5,381 (US$122) in program 3 to
around Rs. 7,000 (US$152) in programs 1 and 2 (Table
1). The health effects per person fitted with hearing aid
equals 0.168, and multiplied by the number of hearings
fitted in the various sites, the number of DALYs averted
ranged between 17 (program 3), 33 (program 2), and 36
(program 1). The cost per DALY averted ranged from
around Rs 34,000 (US$720) in program 3, to Rs. 42,000
(US$900) in programs 1 and 2 (Table 1).
Additional file 1, Table S4 summarizes the main observa-
tions from the survey on patient treatment patterns and
costs. In all sites, there is a diversity of main income-gen-
erating activities. On average, people suffered from hear-
ing impairment between 116 and 139 months, i.e. around
10 years, before enrollment in the present program. The
majority of people being fitted at the primary and second-
ary care levels did consult another provider for treatment
of hearing disorders before enrolment in the present pro-
gram, whereas for the vast majority of people fitted at ter-
tiary care level, this was their first provider. In case other
providers were consulted, this was a private provider in
the vast majority of cases. In all sites, few people had con-
sulted a second other provider. People paid expenses for
fees, drug and tests, transport costs and faced income loss
when consulting providers prior to the present program.
Of patients included in programs 1 and 2, the majority
was identified in the camps through active screening. In
program 3, all patients presented themselves at the health
facility. Patient costs in terms of fees, drugs, tests related to
the first contact in the present program were nearly absent
at the secondary care levels, and significant at tertiary care
level. Income loss of patients and accompanists because
of seeking and undergoing care ranged between Rs.12
(US$0,26) and Rs. 53 (US$1,13) between the different
visits and sites. Costs of food and transport ranged
between Rs. 2 (US$0,04) and Rs. 39 (US$0,83).
Sensitivity analysis was applied to test the robustness of
results towards the use of alternative values on key param-
eters, including the proportion of patients actually wear-
ing hearing aids, the lifetime of the hearing aids, the
difference in health state valuation between treated and
untreated deafness, and cost of hearing aids. This has a
varying impact on study results, individually, and in com-
bination (in a so-called worst case analysis) (Table 2).
Also, we observed that the proportion of people directly
Table 1: Costs, effects and cost-effectiveness of different interventions
Program 1 Program 2 Program 3
Costs
Number of people
People screened at camps 1,926 1,648
Identified at camps 588 534
Fitted with hearing aids, identified through camp (a) 101 163
Fitted with hearing aids, presented at clinic (b) 111 32 100
Total number of patients fitted with hearing aids © = (a)+(b) 212 195 100
Total costs
Fixed project costs (d) 352,631 389,601
Organisation of camps (e) 97,224 64,340
Fitting and follow up, identified through camp (f) 440,975 681,595
Fitting and follow up, presented at clinic (g) 613,961 247,584 569,332
Total (h) = (d)+(e)+(f)+(g) 1,504,790 1,383,120 569,332
Total (US$) (i) 32,154 29,554 12,165
Average cost per patient
Fixed project costs (j) = (d)/(c) 1,663 1,998 -
Organisation of camp (k) = (e)/© 459 330 -
Fitting and follow up (l) = ((f)+(g))/(c) 4,976 4,765 5,693
Total (Rs) (m) = (j)+(k)+(l) 7,098 7,093 5,693
Total (US$) (n) 152 152 122
Health effects
DALYs per patient fitted (p) 0.168 0.168 0.168
Total DALYs averted (q) = (c)*(p) 36 33 17
Cost-effectiveness
Cost (Rs) per DALY averted (r) = (m)/(q) 42,250 42,220 33,889
Cost (US$) per DALY averted (s) = (n)/(q) 903 902 724
BMC Public Health 2009, 9:135 http://www.biomedcentral.com/1471-2458/9/135
Page 5 of 7
(page number not for citation purposes)
presenting to the clinic was much higher in program 1
compared to program 2 (109% of those identified
through camps in program 1, versus 20% of those identi-
fied through camps in program 2). If we assume 109% of
those identified in the community in program 2 to
present themselves directly in the clinic, cost per DALY
decreased to Rs. 32,084 (US$685).
Discussion
Active screening for hearing impairment, including the
provision of hearing aids to eligible patients at primary or
secondary care level, is slightly more costly than fitting of
hearing aids to those people who present themselves for
treatment at the tertiary care level. Cost differences
between the different programs – as cost per patient fitted
with hearing aids – are maximally some 25%, and can be,
given uncertainty about study assumptions, considered to
be moderate only. Active screening programs seem to be
better able than passive screening programs to reach a
higher coverage of hearing aids services in the commu-
nity, and whether this is worth the slightly higher costs is
a matter of judgment.
A number of issues need to be taken into account when
considering the costs estimates. First, and most obvious,
active screening programs do require significant human
and material resources, and these costs add to the average
costs of hearing aids fitted. The cost savings stemming
from treatment at secondary care level instead of treat-
ment at tertiary care level, do offset these costs to a certain
extent. Second, programs 1 and 2 basically concern two
components, i.e. an active screening component in the
community that refers people to the respective health
facility, and another component that involves people who
present themselves directly at the health facility for treat-
ment. We analyze the components in combination, as the
second component would not exist without the first com-
ponent being in place (the information campaign in the
active screening program has likely prompted some peo-
ple to directly present themselves at the health facility for
treatment of hearing disorders, whereas prior to the pro-
gram, no specific hearing treatment was available).
In addition to the detailed cost estimates, this paper also
made some crude estimates of related health effects, and
cost-effectiveness of the hearing aid delivery models. We
estimated that the cost per DALY averted ranged between
around US$720 (passive screening) and US$900 (active
screening). WHO labels interventions as cost-effective if
they cost less than three times GDP per capita, and as not
cost-effective if they cost more than three times GDP per
capita [10]. India has a gross domestic product (GPD) per
capita of US$871 per 2007 [11]. This indicates that, on the
basis of our base-line estimates, both the passive and
active screening programs can be considered as cost-effec-
tive interventions according to international thresholds.
However, sensitivity analysis reveals that alternative val-
ues of key variables can have an important impact of study
results, and e.g. can almost double the cost per DALY
averted in case assumptions on the life time of hearing
aids, or the gain in health state valuation are changed. In
a worst case scenario, the cost per DALY may increase
more than five-fold. Consequently, the above findings
and statement on economic attractiveness needs to be
interpreted with caution.
An interesting observation is that the majority of patients
in the active screening programs had visited a different
health provider before being included in the program
under study. This indicates that the hearing disorders of
the people in the present program did not go undetected
prior to the active screening program, but rather that peo-
ple did not seek care with appropriate health providers.
One possible explanation is that hearing aids were not
delivered free of charge prior to the present program (as
they were in the present program), but at significant costs
Table 2: Sensitivity analysis
Scenario (number, variable) Base-line value Sensitivity analysis Cost per DALY averted
Program 1 Program 2 Program 3
0 Baseline 903 902 724
1 Proportion of patients wearing hearing aid 70% 50% 1264 1,263 1,014
2 idem 70% 90% 702 702 563
3 Lifetime hearing aid (years) 5 3 1,505 1,504 1,207
4 idem 5 7 645 644 517
5 Difference in health state valuation treated and untreated 
deafness
0,048 0,024 1,806 1,804 1,448
6 idem 0,048 0,072 602 601 483
7 Fitted with hearing aids, presented at clinic (program 2 only) 32 179 NA 685 NA
8 Cost of hearing aid Rs. 1,680 (US$36) Rs. 3,000 (US$64) 1,071 1,070 976
9 idem Rs. 1,680 (US$36) Rs. 1,000 (US$21) 816 816 594
10 Worst case scenario (scenarios 1, 3, 5, and 8 combined) Combined Combined 4,996 4,993 4,554
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(similar or above the price as used in our analysis of Rs.
1680 (US$36)), and may not have been affordable to
households. This poses a question concerning the rele-
vance of the screening program, and whether the delivery
of (highly) subsidized hearing aids, in combination with
an (community-based) information campaign publiciz-
ing their availability, may not reach the same objective.
Our study has a number of limitations. Firstly, we only
made a crude assessment of the health effects of hearing
aids by using health state valuations derived from the Glo-
bal Burden of Disease study. This approach does not dif-
ferentiate between the capacities of the secondary and
tertiary health facility levels to diagnose hearing problems
and fit hearing aids. However, recent analyses shows that
the secondary and tertiary care health facilities as included
in our study, are equally effective in that respect [12]. Sec-
ond, our health effects estimates did take into account
compliance of 70% in terms of wearing hearing aids. Lack
of compliance in use is a substantial problem everywhere
among elderly and child hearing aid users, including
those in developing countries [13], and it is not sure
whether our assumptions is realistic. Sensitivity analysis
shows a modest impact on study results. Third, the analy-
sis only included the effects of hearing aids on health, and
not on productivity losses. Several studies have indicated
that such losses may be considerable [14,15]. If these were
included the programs would be rendered more cost-
effective.
Fourth, if screened people are referred for consultation,
but are not found eligible for hearing aids, health facilities
provide additional diagnostic tests for and treatment of
ear-related health problems as a standard procedure (as
such, the screening program also contributes to towards
an integrated primary health care approach). Related
health effects and costs were not included in the analysis,
as the decision to carry out these diagnostic tests and treat-
ment stands by itself [7] and should be subjected to a sep-
arate economic analysis. However, related costs may be
significant and equally relevant in similar contexts, and
policy makers should take these into account when mak-
ing decisions about the funding of the programs at hand.
Fifth, programs were evaluated in two different districts
(program 1 in Karigiri, and programs 2 and 3 in Vellore).
Differences in the epidemiology of disease, and health
care organization between the districts may have con-
founded the results, as well as differences in the organiza-
tion of the screening programs. For example, the
effectiveness of screening appeared higher in program 2
compared to program 1 (163 identified out of 1,648
screened people versus 101 identified out of 1,926
screened people), while fewer people in program 2 pre-
sented directly at the clinic as compared to program 1 (32
versus 111). The reason for these differences is not clear.
However, sensitivity analysis shows only a marginal
effects on cost-effectiveness results, and our study conclu-
sions therefore remain unchanged. Sixth, screening activi-
ties of community workers may not necessarily be limited
only to hearing impairment, but may also include other
diseases and impairments, which would decrease the costs
of hearing impairment screening programs as well as pro-
mote integration of services. Seventh, this study has eval-
uated a universal screening program, and it is not clear
how its results compare to selective screening of high risk
populations, and whether this would be more economi-
cally attractive, and therefore a preferred program.
Baltussen et al. [16] recently reported on costs of three
school-based screening programs in combination with
the provision of hearing aids at respectively primary, sec-
ondary and tertiary care level in China. The study con-
cluded that, in combination with screening, the provision
of hearing aids is least costly at primary care level
(US$227 per child fitted), followed by secondary care
level (US$277) and tertiary care level (US$365). Indian
and Chinese programs cannot be fully compared as the
tertiary care level program in China includes a screening
component, whereas the tertiary care level program in
India study does not. Nevertheless, this leads to a number
of observations. Firstly, the costs per patient fitted with
hearing aids is lower in the community screening program
in India than in the school-based screening program in
China. The cost differences may be explained by many fac-
tors, including differences in the epidemiological profile
of hearing impairments between adults and children, and
between India and China, differences in countries' price
levels, and differences in the nature of the screening pro-
grams themselves. It is thus difficult to draw any conclu-
sion on the relative economic attractiveness of school-
based versus community-based screening for hearing
impairment. Secondly, as in the present Indian study, the
Chinese study reveals only relative small cost differences
between the different programs.
Based on the present study and the study in China [16], a
number of research recommendations can be made.
Firstly, better information is required on the compliance
of people with hearing aids, and on the lifetime of hearing
aids in countries as India and China. Also, the health state
valuations of treated and untreated hearing impairment
are largely Second, local studies can be useful to inform
local policy making, but are difficult to generalize and
therefore hold little relevance for other policy making
context. The above discussion on the comparison between
Indian and Chinese study results illustrate this. We there-
fore argue for multi-country studies that evaluate similar
interventions, and that allow the study of (common) con-
textual factors, such as epidemiology of disease, health
care seeking behavior, the structure of the health care sys-
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tem, and price levels, impacting on costs and health
effects. It is only by the identification of those factors that
results of economic analysis hold broad relevance, i.e.
also beyond the countries directly involved in a (multi-
country) study.
Conclusion
Active screening and provision of hearing aids at the sec-
ondary care level is slightly more costly than passive
screening and fitting of hearing aids at the tertiary care
level. However, the former carries the benefit that it seems
able to reach a higher coverage of hearing aids services and
it can be combined with the screening and management
of other diseases in the community. Although crude esti-
mates indicate that both passive and active screening pro-
grams can be cautiously considered as cost-effective
according to international thresholds, important ques-
tions remain regarding the implementation of the latter.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
RB, VJA, JA & NG designed the study. VJA, NG, BA, JA, JA,
and MP collected the data. RB analyzed the data. All
authors contributed to the drafting of the manuscript.
Additional material
Acknowledgements
The study received funding from the Christian Blind Mission and WWHear-
ing.
References
1. Mathers C, Smith A, Concha M: Global burden of hearing loss in the year
2000 2007 [http://www.who.int/healthinfo/statistics/
bod_hearingloss.pdf]. Geneva: World Health Organisation
2. World Health Organisation: Guidelines for hearing aids and services for
developing countries 2nd edition. Geneva: World Health Organisation;
2004. 
3. Stephens D, Lewis P, Davis A, Gianopoulos I, Vetter N: Hearing aid
possession in the population: lessons from a small country.
Audiology 2001, 40(2):104.
4. Davis A, Smith P, Ferguson M, Stephens D, Gianopoulos I: Accepta-
bility, benefit and costs of early screening for hearing disabil-
ity: a study of potential screening tests and models.  Health
Technol Assess 2007, 11(42):1-294.
5. Information on WWHearing   [http://www.who.int/pbd/deafness/
activities/WWHearing/en/index.html]. (accessed 24-04-2008).
6. Keidser G, Brew C, Peck A: Proprietary fitting algorithms com-
pared with one another and with generic formulas.  Hearing
Journal 2003, 56(3):28-38.
7. Tan-Torres Edejer T, Baltussen R, Adam T, et al.: Making choices in
health: WHO guide to cost-effectiveness analysis Geneva: World Health
Organisation; 2003. 
8. Drummond MF, Sculpher MJ, Torrance GW, O'Brien BJ, Stoddart GL:
Methods for the economic evaluation of health care programmes Third
edition. Oxford: Oxford University Press; 2005. 
9. Murray CJL, Lopez AD: The global burden of disease: a comprehensive
assessment of mortality and disability from diseases, injuries, and risk fac-
tors in 1990 and projected to 2020. Global burden of disease and injury
series Volume 1. Cambridge MA: Harvard School of Public Health;
1996. 
10. World Health Organization: Commission on Macroeconomics and
Health. Macroeconomics and health: investing in health for economic devel-
opment. Report of the Commission on Macroeconomics and Health
Geneva: World Health Organization; 2001. 
11. International Monetary Fund: World Economic and Financial
Surveys.  World Economic Outlook Database. April 2007 edition 2007
[http://www.imf.org/external/pubs/ft/weo/2007/01/data/index.aspx].
12. Presented at WWHearing consultation meeting November
2008, Geneva, Switzerland (unpublished data).  .
13. Furuta H, Yoshino T: The present situation of the use of hear-
ing aids in rural areas of Sri Lanka: problems and future pros-
pects.  Int J Rehabil Res 1998, 21:103-7.
14. Ruben RJ: Redefining the Survival of the Fittest: Communica-
tion Disorders in the 21st Century.  Laryngoscope 2000,
110(2):241-45.
15. Parving A, Christensen B: Training and employment in hearing-
impaired subjects at 20–35 years of age.  Scand Audiol 1993,
22(2):133-9.
16. Baltussen R, Li J, Wu LD, Ge XH, Teng BY, Sun XB, Han R, Wang XL,
McPherson B: Costs of screening children for hearing disor-
ders and delivery of hearing aids in China (unpublished data).
.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-2458/9/135/pre
pub
Additional file 1
Appendix tables. Tables forming appendix
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2458-9-135-S1.doc]
Additional file 2
Appendix questionnaire. Questionnaire about the costs of hearing prob-
lems and its treatment.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2458-9-135-S2.doc]
